摘要
Sox(与SPY相关的HMG盒)家族基因是细胞生长、平衡、再生中重要的调节物质。Sox家族基因某种成员的重整已经被应用于许多包括恶性毒瘤在内人类恶性肿瘤。越来越多的证据表明Sox基因在恶性毒瘤细胞发病机理、生长和增殖方面起着重要的作用。在此,我们综述了基因Sox2 和Sox9在骨肉瘤、软骨肉瘤、脊索瘤,基因Sox2、Sox6和Sox17在尤因肉瘤,基因 Sox2、Sox9和Sox10在滑膜肉瘤,基因Sox2在纤维肉瘤以及Sox21在脂肪肉瘤方面的的生物相关性。这些发现增强了Sox基因在肉瘤方面靶向新型干预治疗的作用,也表现出提高关注肉瘤患者有价值的临床治疗可能性。
关键词: Sox 家族基因;恶性肿瘤;发病机理;靶向治疗
图形摘要
Current Drug Targets
Title:The Roles of Sox Family Genes in Sarcoma
Volume: 17 Issue: 15
Author(s): Jingyuan Li, Jacson Shen, Kunzheng Wang, Francis Hornicek, Zhenfeng Duan
Affiliation:
关键词: Sox 家族基因;恶性肿瘤;发病机理;靶向治疗
摘要: Sox (SRY-related HMG-box) family genes are important regulators of cell development, homeostasis, and regeneration. Deregulation of certain members of the Sox gene family has been implicated in a number of human malignancies, including in sarcoma. Accumulating evidence suggests that Sox genes play crucial roles in sarcoma cell pathogenesis, growth, and proliferation. Here, we review the biological relevance of Sox2 and Sox9 genes in osteosarcoma, chondrosarcoma and chordoma; Sox2, Sox6, and Sox17 genes in Ewing’s sarcoma; Sox2, Sox9, and Sox10 genes in synovial sarcoma; Sox2 gene in fibrosarcoma; and Sox21 gene in liposarcoma. These findings potentiate the targeting of Sox genes for novel therapeutic interventions in sarcoma and may also hold valuable clinical potential to improve the care of patients with sarcoma.
Export Options
About this article
Cite this article as:
Jingyuan Li, Jacson Shen, Kunzheng Wang, Francis Hornicek, Zhenfeng Duan , The Roles of Sox Family Genes in Sarcoma, Current Drug Targets 2016; 17 (15) . https://dx.doi.org/10.2174/1389450117666160502145311
DOI https://dx.doi.org/10.2174/1389450117666160502145311 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genetics of the First Seven Proprotein Convertase Enzymes in Health and Disease
Current Genomics Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets Heparin Derivatives as Angiogenesis Inhibitors
Current Pharmaceutical Design Is Resistance Futile?
Current Drug Targets - Infectious Disorders FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy
Current Drug Targets The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism
Current Alzheimer Research Anti-Cancer Drugs of Today and Tomorrow: Are we Close to Making the Turn from Treating to Curing Cancer?
Current Pharmaceutical Design Effect of Formulations of Nanosized Quercetin Liposomes on COX-2 and NF-kB in MCF-10A Cells
Pharmaceutical Nanotechnology Novel Concepts in the Development of Platinum Antitumor Drugs
Current Medicinal Chemistry - Anti-Cancer Agents KSP Inhibitors as Antimitotic Agents
Current Topics in Medicinal Chemistry Biomaterials and Scaffolds in Bone and Musculoskeletal Engineering
Current Stem Cell Research & Therapy Administration of Drug and Nutritional Components in Nano-Engineered Form to Increase Delivery Ratio and Reduce Current Inefficient Practice
Recent Patents on Drug Delivery & Formulation Cytotoxic Effect of the Red Beetroot (Beta vulgaris L.) Extract Compared to Doxorubicin (Adriamycin) in the Human Prostate (PC-3) and Breast (MCF-7) Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Nanoparticle-Delivered Quercetin for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Influence of Tumor Microenvironment on the Distribution and Elimination of Nano-formulations
Current Drug Metabolism Peptide-Receptor Ligands and Multivalent Approach
Anti-Cancer Agents in Medicinal Chemistry Role of Rap2 and its Downstream Effectors in Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry Telomeres and Thyroid Cancer
Current Genomics The Prominent Role of Protein-Based Delivery Systems on the Development of Cancer Treatment
Current Pharmaceutical Design An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs
Current Topics in Medicinal Chemistry